Skip to content
OpenCapital
Get started

Aclaris Therapeutics ACRS EBIT

EBIT at other companies

Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
-$14.88M-49.9%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
-$43.62M-36.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$20.9M-42.5%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-$15.55M-8.0%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$82.77M-31.2%
Incyte logo
IncyteINCY
——

Other financials

Income statement

See full
Revenue$2.0M+37.2%
Gross profit$1.6M+68.7%
Operating income-$22.2M-22.7%
Net income-$19.8M-31.4%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$28.7M-5.6%
Total debt$2.0M-20.1%
Total equity$143.6M-0.3%
Total assets$198.7M+0.3%

Cash flow

See full
Operating cash flow-$18.1M-39.0%
CapEx$13.0K-69.8%
Free cash flow-$18.2M-38.6%

Valuation

See full
Market cap$685.75M+337%
Enterprise value$659.07M+410%
P/S82×+73.1×

Profitability

See full
Gross margin76.3%-9.7pp
Operating margin-961.9%+259pp
Net margin-832.6%+132pp
FCF margin-624.9%—

Returns & leverage

See full
Return on equity-48.4%-15.4pp
Debt / equity0×0.0×
Current ratio4×-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

−$22.2Moperating income=-$22.19M

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aclaris Therapeutics's EBIT?
Aclaris Therapeutics (ACRS) reported EBIT of -$22.19M in Q1 2026.
How has Aclaris Therapeutics's EBIT changed year-over-year?
Aclaris Therapeutics's EBIT decreased by 22.7% year-over-year, from -$18.08M to -$22.19M.
What is the long-term trend for Aclaris Therapeutics's EBIT?
Over 4 years (2021 to 2025), Aclaris Therapeutics's EBIT has grown at a -3.9% compound annual growth rate (CAGR), from -$89.72M to -$76.38M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.